Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes

Toxicology in Vitro

Volumn 23, Issue 1, 2009, Pages 78-82

  Seibt, Kelly Juliana ^a   Oliveira, Renata da Luz ^a   Rico, Eduardo Pacheco ^b   Dias, Renato Dutra ^a   Bogo, Mauricio Reis ^c   Bonan, Carla Denise ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Faculdade de Biociencias   (Brazil)

Author keywords

Antipsychotic; Ectonucleotidase; Haloperidol; Olanzapine; Schizophrenia; Sulpiride; Zebrafish

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ATYPICAL ANTIPSYCHOTIC AGENT; ECTONUCLEOTIDASE; HALOPERIDOL; NEUROLEPTIC AGENT; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; OLANZAPINE; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYDROLYSIS; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE HYDROLYSIS; ZEBRA FISH;

5'-NUCLEOTIDASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HALOPERIDOL; HYDROLYSIS; INTRACELLULAR MEMBRANES; MALE; NUCLEOSIDE-TRIPHOSPHATASE; SULPIRIDE; ZEBRAFISH;

DANIO RERIO;

EID: 58149312970     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.10.003     Document Type: Article

References (41)

1. Agteresch H.J., Dagnelie P.C., Van den Berg J.W., and Wilson J.H. Adenosine triphosphate: established and potential clinical applications. Drugs 58 2 (1999) 211-232
2. Barnes J.M., Murphy P.A., Kirkham D., and Henley J.M. Interaction of guanine nucleotides with [3H] kainate and 6-[3H] cyano-7-nitroquinoxaline-2,3-dione binding in goldfish brain. Journal of Neurochemistry 61 (1993) 1685-1691
3. Bodin P., and Burnstock G. Purinergic signalling: ATP release. Neurochemical Research 26 8-9 (2001) 959-969
4. Boehmler W., Carr T., Thisse C., Thisse B., Canfield V.A., and Levenson R. D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour. Genes, Brain and Behavior 6 2 (2007) 155-166
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 218-254
6. Brunstein M.G., Silveira Jr. E.M., Chaves L.S., Machado H., Schenkel O., Belmonte-de-Abreu P., Souza D.O., and Lara D.R. Increased serum adenosine deaminase activity in schizophrenic receiving antipsychotic treatment. Neuroscience Letters 414 1 (2007) 61-64
7. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacological Reviews 58 (2006) 58-86
8. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nature Reviews Drug Discovery 7 7 (2008) 575-590
9. +)-ATPase activity. Molecular Pharmacology 44 (1993) 129-141
10. 2+ -ATPase activity. Analytical Biochemistry 157 (1986) 375-380
11. Dodd A., Curtis P.M., Williams L.C., and Love D.A. Zebrafish: bridging the gap between development and disease. Human Molecular Genetics 9 16 (2000) 2443-2449
12. Dooley K., and Zon L.I. Zebrafish: a model system for the study of human disease. Current Opinion in Genetics and Development 10 (2000) 252-256
13. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 45 9 (1988) 789-796
14. Fetcho J.R., and Liu K.S. Zebrafish as a model system for studying neuronal circuits and behavior. Annals of the New York Academy of Sciences 860 (1998) 333-345
15. Fleischhacker W.W. Clozapine: a comparison with other novel antipsychotics. Journal of Clinical Psychiatry 60 (Suppl. 12) (1999) 30-34
16. Fredholm B., Ijzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 53 4 (2001) 527-552
17. Gerlai R., Lahav S., Guo S., and Rosenthal A. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacology, Biochemistry and Behavior 67 (2000) 773-782
18. Giacomini N.J., Rose B., Kobayashi K., and Guo S. Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicology Teratology 28 2 (2006) 245-250
19. Grinthal A., and Guidotti G. CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why?. Purinergic Signalling 2 (2006) 391-398
20. Hill A.J., Teraoka H., Heideman W., and Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicological Sciences 86 (2005) 6-19
21. Ivetac I., Becanovic J., and Krishnapillai V. Zebrafish: genetic tools and genomics. Asia-Pacific Journal of Molecular Biology and Biotechnology 8 (2000) 1-11
22. Jutila A., Soderlund T., Pakkanen A.L., Huttunen M., and Kinnunen P.K. Comparison of the effects of clozapine, chlorpromazine, and haloperidol on membrane lateral heterogeneity. Chemistry and Physics Lipids 112 (2001) 151-163
23. Kapur S., Zipursky R.B., and Remington G. Clinical and theoretical implications of 5-HT and D2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia. American Journal of Psychiatry 156 2 (1999) 286-293
24. Lara D.R., and Souza D.O. Schizophrenia: a purinergic hypothesis. Medical Hypotheses 54 (2000) 157-166
25. Lara D.R., Dall'Igna O.P., Ghisolfi E.S., and Brunstein M.G. Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications. Progress in Neuropsychopharmacology 30 (2006) 617-629
26. 2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics. Journal of Psychiatric Research 40 1 (2006) 81-88
27. Mazumder B., Mukherjee S., and Sen P.C. The chlorpromazine inhibition of transport ATPase and acetylcholinesterase activities in the microsomal membranes of rat in vitro and in vivo. Molecular and Cellular Biochemistry 95 1 (1990) 13-20
28. Papanikolaou A., Papafotika A., Murphy C., Papamarcaki T., Tsolas O., Drab M., Kurzchalia T.V., Kasper M., and Christoforidis S. Cholesterol-dependent lipid assemblies regulate the activity of the ectonucleotidase CD39. Journal of Biological Chemistry 15 (2005) 26406-26414
29. Pedrazza E.L., Senger M.R., Pedrazza L., Zimmermann F.F., Sarkis J.J.F., and Bonan C.D. Sertraline and clomipramine inhibit nucleotide catabolism in rat brain synaptosomes. Toxicology In Vitro 21 (2007) 671-676
30. Phillis J.W., and Wu P.H. The role of adenosine and its nucleotides in central synaptic Transmission. Progress in Neurobiology 16 (1981) 187-239
31. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacological Review 50 3 (1998) 413-492
32. Rico E.P., Senger M.R., Fauth M.G., Dias R.D., Bogo M.R., and Bonan C.D. ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio). Life Science 73 (2003) 2071-2082
33. Robson S.R., Sevigny J., and Zimmermann Z. The E-NTPDase family of ecto-nucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2 (2006) 409-430
34. Seeman P. Atypical antipsychotics: mechanism of action. Canadian Journal of Psychiatry 47 1 (2002) 27-28
35. Senger M.R., Rico E.P., Dias R.D., Bogo M.R., and Bonan C.D. Ecto-5′-nucleotidase activity in brain membranes of zebrafish (Danio rerio). Comparative Biochemistry and Physiology 139 2 (2004) 203-207
36. Sträter N. Ecto-5_-nucleotidase: structure function relationships. Purinergic Signalling 2 (2006) 343-350
37. Tessier C., Nuss P., Staneva G., and Wolf G. Modification of membrane heterogeneity by antipsychotic drugs: an X-ray diffraction comparative study. Journal of Colloid and Interface Science 320 (2008) 469-475
38. Wadenberg M.L., Soliman A., VandenSpek S.C., and Kapur S. Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25 5 (2001) 633-641
39. Zimmermann H. 5′- nucleotidase: molecular structure and functional aspects. The Biochemical Journal 285 (1992) 345-365
40. Zimmermann H. Biochemistry, location and functional roles of ecto-nucleotidases in the nervous system. Progress in Neurobiology 49 (1996) 589-618
41. Zimmermann H. Ecto-nucleotidases: some recent developments and a note on nomenclature. Drug Development Research 52 (2001) 44-56